The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo
To the Editor: The Vitiligo Extent Score (VES) is a reliable and valid instrument to assess vitiligo extent at a specific time point (ie, static assessment), but its ability to detect changes (ie, dynamic assessment) is still unclear. 1 Because vitiligo experts' main concern related to the VES was the absence of an integrated perifollicular repigmentation pattern, the original instrument was modified (ie, VESplus) to optimize precision in case of treatment evaluation (Fig 1; added perifollicular scale in the VESplus). 2 In a recent, related research letter, we confirmed the validity and reliability of this modified tool (VESplus). 3 In this study, we evaluated the responsiveness of the VESplus and its reliability to detect changes compared with the VES. In addition, the possible use for both global (ie, total body) and regional assessment of repigmentation (ie, all locations separately) were investigated.
VES and VESplus were independently performed on paired pictures of 2 time points of vitiligo patients on cream ( group 1, n ¼ 28; 3 raters) or ultraviolet B therapy ( group 2, n ¼ 29; 2 raters). Responsiveness was evaluated by 3 predefined hypotheses (ie, construct approach). 4 If all hypotheses were in accordance with the results, it was assumed that there was evidence for adequate responsiveness. The 3 hypotheses defined were 1) percentage repigmentation after ultraviolet B would be $ 10% higher (on average) compared with topical treatments; 2) in patients with improvement, lesions on the face would have $10% higher repigmentation than lesions on the hands; and 3) there would be a coefficient of rank correlation $0.5 between the method and global assessment score. The global assessment score on a 5-point scale (clear worsening [e2] to clear improvement [12] ) was performed by an expert (Dr Wolkerstorfer). Approval by ethics committees was obtained.
Inter-and intrarater reliability (interval between ratings 6 2 weeks or more) of VESplus and VES were investigated on the observed differences between the paired pictures by calculating the intraclass correlation coefficent, which was acceptable if $0.70. To investigate if the VES or VESplus could be more sensitive to detect small changes, the number of cases in which no difference was observed between the 2 time points was compared by using the Fisher's exact test.
All hypotheses were confirmed, and inter-and intrarater reliability for global and regional assessment of responsiveness were good to excellent for both instruments, with similar results in case of perifollicular repigmentation (Table I) . VES and VESplus showed no significant difference by Wilcoxon analysis and Bland-Altman plots (data not shown), although in group 2 small differences per region were detected better by the VESplus than the VES (P ¼ .008): 80.7% (176/218) versus 69.3% (151/218), respectively.
In conclusion, both VES and VESplus appeared to be responsive instruments. However, further studies are required to make conclusions on the most preferred tool. A limitation that might have Added perifollicular repigmentation scale in the VESplus (range 5%-90%). In each region, the VESplus score is regional VES score 3 [(100 e estimated percentage of perifollicular repigmentation score)/100]. The total VESplus score is the sum of each regional score. VES, Vitiligo Extent Score. Table I . Inter and intra-observer reliability of the responsiveness, assessing differences between time point 1 and 2, for VESplus and VES BSA, Body surface area; CI, confidence interval; UVB, ultraviolet B; VES, Vitiligo Extent Score; VESplus, Vitiligo Extent Score plus. *Group 1 included 14 female and 14 male patients of age range 12-66 years; 93% had a photo skin type #4. Group 1 used topical therapy (topical corticosteroids and immunomodulators). Group 2 included 15 female and 14 male patients of age range 13-68 years; 76% had photo type skin #4. Group 2 used 311-nm narrowband UVB therapy combined with topical steroids. One patient in each group received additionally systemic corticosteroids.
influenced our study results was the lack of diversity in our patient population: perifollicular repigmentation was absent in two thirds of cases, mean body surface area was\5% in 93% of the population, and photo skin type was #4 in 84% of the study population. Furthermore, future studies will be needed to compare these scoring systems directly to existing scoring systems like the Vitiligo European Task Force assessment and Vitiligo Area Scoring Index.
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